• Corpus ID: 53356727

Histone lysine demethylases as epigenetic modifiers in HPV-induced cervical neoplasia

@inproceedings{Iancu2015HistoneLD,
  title={Histone lysine demethylases as epigenetic modifiers in HPV-induced cervical neoplasia},
  author={Iulian Iancu and Anca Botezatu and Adriana Plesa and Irina Huică and Demetra Gabriela Socolov and Gabriela Anton and Stefan S. Nicolau and Grigore T. Popa},
  year={2015}
}
Epidemiologic data confirmed high-risk human papillomaviruses as etiological agents of cervical cancer. On the other hand genetic and epigenetic modifications are known to play an important role in carcinogenesis. Histone lysine-specific demethylases (KDMs) have been shown to contribute to development and progression of many types of cancer. We evaluated the possible role of KDMs in cervix oncogenesis by analysing their expression in patients with HPV-induced cervical lesions and cancer (86… 

Figures and Tables from this paper

Human papillomavirus dysregulates the cellular apparatus controlling the methylation status of H3K27 in different human cancers to consistently alter gene expression regardless of tissue of origin

A model whereby HPV-mediated dysregulation of CDKN2A transcription requires KDM6A, a potentially druggable target is supported, which supports restoration of normal p16 regulation against HPV induced cancers.

The Involvement of Epigenetic Mechanisms in HPV‐Induced Cervical Cancer

HPV infection role in chromatin modification/ remodeling and the impact of HPV infection on non‐coding RNAs in cervix oncogene‐ sis are reviewed.

Epigenetic Regulation of the Human Papillomavirus Life Cycle

Recent advances in the understanding of epigenetic modifications associated with HPV infections are highlighted, with a particular focus on the role of these epigenetic changes during different stages of the HPV life cycle that are closely associated with activation of DNA damage response pathways.

Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells

This study corroborates the development of genistein as a candidate for anti-cancer therapy and presents a comprehensive mechanism of action ofgenistein showcasing effective epigenetic modulation and widespread transcriptional changes resulting in restoration of tumour suppressor gene expression.

Epigallocatechin gallate inhibits HeLa cells by modulation of epigenetics and signaling pathways

This study comprehensively explains EGCG’s anti-cancer mechanism via the synchronized transcriptional alteration of several molecular targets across different signaling pathways and reversal of tumour suppressor gene silencing through modulation of epigenetic enzymes.

RETRACTED ARTICLE: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis

Cervical cancer is the fourth most frequent cancer in women worldwide and a major cause of mortality in developing countries. Persistent infection with high-risk human papillomavirus (HPV) is a

Retraction Note: Molecular mechanisms in progression of HPV-associated cervical carcinogenesis

The Editor-in-Chief has retracted this article [1] due to significant overlap with previously published articles [2–5]. Both authors agree with this retraction.

References

SHOWING 1-10 OF 32 REFERENCES

Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming

It is shown that repressive trimethyl marks on lysine 27 of histone 3, which are necessary for binding of polycomb repressive complexes, are decreased in HPV16 E7-expressing cells and HPV16-positive cervical lesions and are reversed when E7 expression is silenced, indicating that this pathway may have prognostic and/or therapeutic significance.

Genomic amplification and oncogenic properties of the GASC1 histone demethylase gene in breast cancer

GASC1 is a driving oncogene in the 9p23–24 amplicon in human breast cancer and targeted inhibition of GASC1 histone demethylase in cancer could provide potential new avenues for therapeutic development.

The emerging role of histone lysine demethylases in prostate cancer

The emerging role of KDMs in regulating the metastatic potential and androgen-dependence of PCa is summarized and the possible interaction between KDMs and other epigenetic effectors relevant for PCa TICs is speculated.

Interaction of the HPV E7 proteins with the pCAF acetyltransferase

The interaction of the HPV 6, 16 and 18 E7 proteins with the pCAF acetyltransferase provides new insight into the mechanisms by which the E7 oncoproteins can alter cellular gene expression and growth.

Genome-wide siRNA screen identifies SMCX, EP400, and Brd4 as E2-dependent regulators of human papillomavirus oncogene expression

An unbiased, genome-wide siRNA screen and series of secondary screens that identified 96 cellular genes that contribute to the repression of the HPV LCR confirmed a role for the E2-binding bromodomain protein Brd4 in E2 -mediated silencing, indicating that E2 functions through several distinct cellular complexes to repress E6 and E7 expression.

Epigenetic regulation of cancer growth by histone demethylases

The observation that overexpression, amplification or mutations of several histone demethylases have been found in many types of tumors, raise the possibility of using these enzymes as diagnostic tools as well as pave a way for the discovery of novel therapeutic targets and treatment modalities.

The Binding of Histone Deacetylases and the Integrity of Zinc Finger-Like Motifs of the E7 Protein Are Essential for the Life Cycle of Human Papillomavirus Type 31

It is demonstrated that the interaction of E7 with HDACs and the integrity of the zinc finger-like motifs are essential for extending the life span of keratinocytes and for stable maintenance of viral genomes.

Interaction between the HPV E7 oncoprotein and the transcriptional coactivator p300

It is shown that E7 can abolish the p300-mediated E2 transactivation function, suggesting that complex formation between E7 and p300 may contribute to the regulation of E2 transcriptional activity.

Cancer epigenomics: DNA methylomes and histone-modification maps

It is time to 'upgrade' cancer epigenetics research and put together an ambitious plan to tackle the many unanswered questions in this field using epigenomics approaches.